MedPath

An Observational Study to Evaluate Lymph Metastases and Prognoses of the Patients With Esophageal Cancer

Conditions
Esophageal Cancer
Interventions
Procedure: Surgeries
Registration Number
NCT03415815
Lead Sponsor
Henan Cancer Hospital
Brief Summary

The real-world observational study was designed to explore lymph metastases and prognoses of the Chinese patients with thoracic T1-T3 esophageal cancer

Detailed Description

This trial is a real-world non-interventional observational study. The Chinese patients with thoracic T1-T3 esophageal cancer enrolled from Jan.1999 to Jun.2017 were included and the study data on pathologically diagnosed patient demographic/tumor biological characteristics were collected to evaluate the relevance of lymph metastases and prognoses of the subjects.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
3673
Inclusion Criteria
  • Patients >= 18 years old;
  • Patients who received radical resection of esophageal cancer;
  • Pathologically diagnosed patients with thoracic T1-T3 esophageal cancer after surgeries;
Exclusion Criteria
  • Patients who received upper gastrointestinal surgeries;
  • Patients with second primary tumors;

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
T1-T3 esophageal cancerSurgeriesPathologically diagnosed patients with T1-T3 esophageal cancer who received surgeries
Primary Outcome Measures
NameTimeMethod
Numbers of lymph nodes and percentages of patients with surgeries1999 - 2017

Numbers of lymph nodes and percentages of patients with surgeries in the patients with thoracic T1-T3 esophageal cancer

Secondary Outcome Measures
NameTimeMethod
Impact factors of lymph metastases1999 - 2017

Impact factors of lymph metastases

Trial Locations

Locations (10)

China-Japan Friendship Hospital

🇨🇳

Beijing, Beijing, China

China PLA General Hospital

🇨🇳

Beijing, Beijing, China

Henan cancer hospital

🇨🇳

Zhengzhou, Henan, China

Tongji Hospital Affiliated to Huazhong Technology Hospital

🇨🇳

Wuhan, Hubei, China

Jiangsu cancer hospital

🇨🇳

Nanjing, Jiangsu, China

Huaxi Hospital Affiliated to Sichuan University

🇨🇳

Chendu, Sichuan, China

Xi'an Tangdu Hospital

🇨🇳

Xi'an, Shaanxi, China

Shanghai Chest Hospital

🇨🇳

Shanghai, Shanghai, China

First Hospital Affiliated to Zhejiang University

🇨🇳

Hangzhou, Zhejiang, China

Tianjin Chest Hospital

🇨🇳

Tianjin, Tianjin, China

© Copyright 2025. All Rights Reserved by MedPath